Bo Martin Bibby

Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Accurate quantification of regional liver function is needed, and PET of specific hepatic metabolic pathways offers a unique method for this purpose. Here, we quantify hepatic galactose elimination in humans using PET and the galactose analog 2-(18)F-fluoro-2-deoxy-d-galactose ((18)F-FDGal) as the PET tracer.
Original languageEnglish
JournalJournal of Nuclear Medicine
Pages (from-to)1566-1572
Number of pages7
Publication statusPublished - 29 Aug 2011

    Research areas

  • Aged, Female, Fluorine Radioisotopes, Fucose, Galactose, Humans, Infusions, Intravenous, Kinetics, Liver, Liver Circulation, Male, Middle Aged, Positron-Emission Tomography, Radiopharmaceuticals, Reference Values, Tomography, X-Ray Computed

See relations at Aarhus University Citationformats

ID: 41989299